CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and Australasian research organisations.
Applications are sought from researchers working in a CSL Therapeutic Area and a Focus Area, and that are amenable to or include a Modality listed below:
Funder: CSL
Funding opportunity: Research Acceleration Initiative
Funding: $250k p.a. for up to 2 years (max $500k funding)
Funder Close date: Friday 13 March 2020
Therapeutic Areas
(emphasis on rare disease)
• Immunology
• Neurology
• Haematology
• Thrombosis
• Transplant
• Respiratory
• Cardiovascular/Metabolic
Focus Areas
• Novel drug targets
• Novel therapeutic candidates
• Novel strategies for treating disease
Modalities
• Antibodies
• Protein therapeutics
• Gene therapies
• Cell therapies
• Small molecules not of interest
A copy of the Application Form can be found here and further information is available in the flyer.
For questions and to apply please email Dr. Bo Yun or Dr. Alison Greenway
No comments:
Post a Comment